These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7862456)
1. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Bartkova J; Lukas J; Strauss M; Bartek J Oncogene; 1995 Feb; 10(4):775-8. PubMed ID: 7862456 [TBL] [Abstract][Full Text] [Related]
2. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Nielsen NH; Emdin SO; Cajander J; Landberg G Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115 [TBL] [Abstract][Full Text] [Related]
3. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583 [TBL] [Abstract][Full Text] [Related]
4. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812 [TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 gene expression in human cervical neoplasia. Nichols GE; Williams ME; Gaffey MJ; Stoler MH Mod Pathol; 1996 Apr; 9(4):418-25. PubMed ID: 8729983 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Lukas J; Pagano M; Staskova Z; Draetta G; Bartek J Oncogene; 1994 Mar; 9(3):707-18. PubMed ID: 8108113 [TBL] [Abstract][Full Text] [Related]
7. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. McIntosh GG; Anderson JJ; Milton I; Steward M; Parr AH; Thomas MD; Henry JA; Angus B; Lennard TW; Horne CH Oncogene; 1995 Sep; 11(5):885-91. PubMed ID: 7675447 [TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550 [TBL] [Abstract][Full Text] [Related]
10. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Bartkova J; Lukas J; Strauss M; Bartek J Int J Cancer; 1994 Aug; 58(4):568-73. PubMed ID: 8056453 [TBL] [Abstract][Full Text] [Related]
11. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Oyama T; Kashiwabara K; Yoshimoto K; Arnold A; Koerner F Cancer Res; 1998 Jul; 58(13):2876-80. PubMed ID: 9661905 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. Bartkova J; Lukas J; Strauss M; Bartek J J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927 [TBL] [Abstract][Full Text] [Related]
14. Expression of cyclins D1 and E in human colon adenocarcinomas. Sutter T; Doi S; Carnevale KA; Arber N; Weinstein IB J Med; 1997; 28(5-6):285-309. PubMed ID: 9604788 [TBL] [Abstract][Full Text] [Related]
15. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405 [TBL] [Abstract][Full Text] [Related]
17. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein. Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754 [TBL] [Abstract][Full Text] [Related]
18. Abundance and subcellular localisation of cyclin D3 in human tumours. Bartkova J; Zemanova M; Bartek J Int J Cancer; 1996 Jan; 65(3):323-7. PubMed ID: 8575852 [TBL] [Abstract][Full Text] [Related]
19. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124 [TBL] [Abstract][Full Text] [Related]
20. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Naidu R; Wahab NA; Yadav MM; Kutty MK Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]